The retinoblastoma tumor-suppressor protein (Rb) plays a critical role in controlling cellular proliferation and apoptosis by regulating E2F transcription factors. Rb is a key target of oncoproteins expressed by DNA tumor viruses, but RNA viruses are not known to regulate Rb function. Here, we show that Rb abundance is negatively regulated in cells containing replicating genomic RNA from hepatitis C virus, a human virus strongly associated with hepatocellular carcinoma. The viral RNA-dependent RNA polymerase NS5B forms a complex with Rb, targeting it for degradation and resulting in reduction of Rb abundance, activation of E2F-responsive promoters, and cell proliferation. NS5B contains a conserved Leu-x-Cys͞Asn-x-Asp motif that is homologous to Rb-binding domains in the oncoproteins of DNA viruses. This domain overlaps the polymerase active site, and mutations within it abrogate Rb binding and reverse the effects of NS5B on E2F promoter activation and cell proliferation. These findings suggest a unique link between an oncogenic RNA virus implicated in the development of liver cancer and a critically important tumor-suppressor protein.cell cycle regulation ͉ chronic hepatitis ͉ E2F transcription factor ͉ hepatocellular carcinoma ͉ viral oncogenesis H epatitis C virus (HCV) infection is a leading cause of morbidity and mortality in many human populations (1). Persons with persistent HCV infection are at increased risk of developing cirrhosis and hepatocellular carcinoma (2). The strong association between hepatocellular carcinoma and HCV infection is particularly notable in that HCV is a positive-strand RNA virus, classified within the genus Hepacivirus of the family Flaviviridae. Its 9.6-kb genome replicates exclusively within the cytoplasm (3) and encodes a single, large polyprotein that is processed by cellular and viral proteases into only 10 individual structural and nonstructural viral proteins. Although inflammation associated with chronic hepatitis C is likely to contribute to the development of hepatocellular carcinoma, there is evidence that one or more of the proteins expressed by the virus contribute directly to carcinogenesis. Transgenic mice expressing a high abundance of the core protein develop hepatocellular carcinoma and steatosis (4). Liver cancer also developed in transgenic mice expressing a much lower abundance of the entire viral polyprotein but not in a companion transgenic lineage expressing a higher abundance of the structural proteins (core, E1, E2, and p7) only (5). Such data suggest a direct role for both structural and nonstructural proteins of HCV in oncogenesis.Mechanisms that regulate cell-cycle progression are frequently disrupted in hepatocellular carcinomas associated with HCV infection. These regulatory mechanisms include the retinoblastoma protein (Rb) (6), which plays a major role in controlling the G1 to S-phase transition through a repressive effect on E2F transcription factors (7). Rb functions as a tumor suppressor, and the gene which encodes it (RB) is frequently mutated...